The Braid Reinforced Catheter Shafts segmentation by application delineates four principal end‑use groups that together drive the market’s revenue composition. Cardiovascular procedures, encompassing coronary angiography and interventional cardiology, represent the largest share, accounting for roughly 40 % of total sales due to the high procedural volume and stringent performance requirements for torque transmission. Neurovascular applications, such as cerebral aneurysm coiling and stroke thrombectomy, contribute about 30 % as the shift toward minimally invasive neurosurgery fuels demand for high‑flexibility shafts. Peripheral interventions—including peripheral artery disease treatment and dialysis access—capture an estimated 20 % of the market, reflecting moderate growth tied to an aging patient base. The residual 10 % falls under Other categories, covering urological, gastrointestinal and experimental research uses, where niche specifications drive modest sales. Collectively, these application segments define the market size, with each proportion directly linked to procedural frequency, regulatory pathways, and reimbursement structures. Analysts project that emerging hybrid procedures will modestly shift these ratios, particularly expanding the neurovascular share by 2–3 % over the next five years.
